Gandhi Damaj - Dissemin

Language
Login

All papers authored by Gandhi Damaj

This paper is made freely available by the publisher.

2023 Herve Ghesquieres, Fanny Cherblanc, Aurelien Belot

ORCID

, Sophie Micon, Krimo Bouabdallah, Cyril Esnault

ORCID

, Luc-Matthieu Fornecker, Katia Thokagevistk, Maxime Bonjour, Fontanet Bijou

ORCID

, Corinne Haioun, Nadine Morineau, Loïc Ysebaert, Gandhi Damaj

ORCID

, Benoit Tessoulin

ORCID

and 33 other authors

Challenges for quality and utilization of real-world data for diffuse large B-cell lymphoma in REALYSA, a LYSA cohort

Download from doi.org

This paper is made freely available by the publisher.

Raphaelle Aubrais, Krimo Bouabdallah, Loic Chartier, Charles Herbaux, Anne Banos, Pauline Brice, David Sibon

ORCID

, Jean Marc Schiano

ORCID

, Thomas Cluzeau, Kamel Laribi, Ronan Le Calloch

ORCID

, Mathieu Bellal, Baptiste Delapierre, Nicolas Daguindau, Sandy Amorim and 11 other authors

Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA group

Download from doi.org

This paper is made freely available by the publisher.

Emmanuel Bachy

ORCID

, Kerry J. Savage

ORCID

, Huiqiang Huang, Yok-Lam Kwong, Giuseppe Gritti

ORCID

, Qingyuan Zhang, Anna Marina Liberati, Junning Cao, Haiyan Yang, Siguo Hao, Jianda Hu, Keshu Zhou

ORCID

, Mario Petrini

ORCID

, Filomena Russo, Huilai Zhang and 16 other authors

Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study

Download from doi.org

This paper is made freely available by the publisher.

Guillaume Cartron

ORCID

, Emmanuel Bachy

ORCID

ORCID

, Nicolas Daguindau, Gian-Matteo Pica, Fontanet Bijou

ORCID

, Christiane Mounier, Aline Clavert, Gandhi Laurent Damaj

ORCID

, Borhane Slama, Olivier Casasnovas

ORCID

ORCID

, Krimo Bouabdallah, David Sibon

ORCID

, Olivier Fitoussi and 16 other authors

Randomized Phase III Trial Evaluating Subcutaneous Rituximab for the First-Line Treatment of Low–Tumor Burden Follicular Lymphoma: Results of a LYSA Study

Download from doi.org

This paper is made freely available by the publisher.

2022 Paul Lesueur

ORCID

, Gandhi Damaj

ORCID

, Khê Hoang-Xuan, Virginie Roland, Anna Schmitt

ORCID

, Olivier Chinot

ORCID

, Michel Fabbro

ORCID

, Philippe Agapé, Cécile Moluçon-Chabrot, Safia Chebrek, Agusti Alentorn, Loic Feuvret, Daniel Delgadillo, Dinu Stefan, Sylvain Choquet and 6 other authors

Reduced-dose WBRT as consolidation treatment for patients with primary CNS lymphoma: an LOC network study

Download from doi.org

This paper is made freely available by the publisher.

Caroline Houillier

ORCID

, Sylvain Dureau, Luc Taillandier, Roch Houot

ORCID

, Olivier Chinot

ORCID

, Cécile Moluçon-Chabrot, Anna Schmitt, Rémy Gressin, Sylvain Choquet

ORCID

, Gandhi Damaj

ORCID

, Frédéric Peyrade, Julie Abraham, Vincent Delwail, Emmanuel Gyan, Laurence Sanhes

ORCID

and 18 other authors

Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients Age 60 Years and Younger: Long-Term Results of the Randomized Phase II PRECIS Study

Download from doi.org

This paper is made freely available by the publisher.

Laurence Schenone, Caroline Houillier, Marie Laure Tanguy, Sylvain Choquet, Kossi Agbetiafa, Hervé Ghesquières, Gandhi Damaj

ORCID

, Anna Schmitt, Krimo Bouabdallah, Guido Ahle, Remy Gressin, Jérôme Cornillon, Roch Houot, Jean-Pierre Marolleau, Luc-Matthieu Fornecker and 41 other authors

Intensive chemotherapy followed by autologous stem cell transplantation in primary central nervous system lymphomas (PCNSLs). Therapeutic outcomes in real life—experience of the French Network

Download from www.nature.com

This paper was not found in any repository, but could be made available legally by the author.

Domitille Costes-Tertrais

ORCID

, Thomas Hueso, Thomas Gastinne, Catherine Thieblemont

ORCID

, Lucie Oberic, Krimo Bouabdallah, Sylvain Garciaz, Emmanuelle Tchernonog, Caroline Dartigeas, Vincent Ribrag, Patrick Fogarty, René-Olivier Casasnovas

ORCID

, Roch Houot, Caroline Delette, Sandra Malak

ORCID

and 4 other authors

Bendamustine-EAM versus R-BEAM after high-dose cytarabine-based induction in newly diagnosed patients with mantle cell lymphoma, a LYSA retrospective study

Upload

This paper is made freely available by the publisher.

2021 Vincent Camus, Cédric Rossi

ORCID

, Pierre Sesques, Justine Lequesne, David Tonnelet

ORCID

, Corinne Haioun, Eric Durot

ORCID

, Alexandre Willaume, Martin Gauthier

ORCID

, Marie-Pierre Moles-Moreau, Chloé Antier, Julien Lazarovici, Hélène Monjanel, Sophie Bernard, Magalie Tardy and 17 other authors

Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA study

Download from doi.org

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Steven Le Gouill

ORCID

, Hervé Ghesquières, Lucie Oberic

ORCID

, Franck Morschhauser

ORCID

, Hervé Tilly, Vincent Ribrag, Thierry Lamy, Catherine Thieblemont, Hervé Maisonneuve, Rémy Gressin, Krimo Bouhabdallah, Corinne Haioun, Gandhi Damaj

ORCID

, Luc Fornecker, Réda Bouhabdallah and 15 other authors

Obinutuzumab vs rituximab for advanced DLBCL: a PET-guided and randomized phase 3 study by LYSA

Upload

This paper is made freely available by the publisher.

Benoit Tessoulin

ORCID

, David Chiron, Catherine Thieblemont, Lucie Oberic, Kamal Bouadballah, Emmanuel Gyan

ORCID

, Gandhi Damaj

ORCID

, Vincent Ribrag, Rémy Gressin, Pierre Feugier, Olivier Casasnovas

ORCID

, Hacène Zerazhi, François Lemonnier, Hervé Maisonneuve, Clementine Joubert and 6 other authors

Oxaliplatin before autologous transplantation in combination with high-dose cytarabine and rituximab provides longer disease control than cisplatin or carboplatin in patients with mantle-cell lymphoma: results from the LyMA prospective trial

Download from www.nature.com

Distributing this paper is prohibited by the publisher

Cedric Pastoret, Fabienne Desmots-Loyer, Gaelle Drillet, Simon Le Gallou, Marie-Laure Boulland, Alexia Thannberger, Anne-Violaine Doncker, Véronique Salaun, Gandhi Laurent Damaj

ORCID

, Richard Veyrat-Masson, Olivier Tournilhac

ORCID

, Aline Moignet, Celine Pangault

ORCID

, Mikael Roussel, Thierry Fest and 1 other authors

Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells

Upload

This paper was not found in any repository, but could be made available legally by the author.

Lucie Oberic, Frederic Peyrade, Mathieu Puyade, Christophe Bonnet, Peggy Dartigues-Cuillères, Bettina Fabiani, Philippe Ruminy, Hervé Maisonneuve, Julie Abraham, Catherine Thieblemont

ORCID

, Pierre Feugier, Gilles Salles

ORCID

, Fontanet Bijou

ORCID

, Gian-Matteo Pica, Gandhi Damaj

ORCID

and 10 other authors

Subcutaneous Rituximab-MiniCHOP Compared With Subcutaneous Rituximab-MiniCHOP Plus Lenalidomide in Diffuse Large B-Cell Lymphoma for Patients Age 80 Years or Older

Upload

Distributing this paper is prohibited by the publisher

2020 Norbert Schmitz, Lorenz H. Truemper

ORCID

, Krimo Bouabdallah, Marita Ziepert, Mathieu Leclerc, Guillaume Cartron

ORCID

, Arnaud Jaccard, Peter Reimer, Eva Maria Wagner-Drouet, Martin Wilhelm, Laurence Sanhes, Thierry Lamy, Laurence de Leval, Andreas Rosenwald, Murielle Roussel

ORCID

and 26 other authors

A randomized phase 3 trial of auto vs. allo transplantation as part of first-line therapy in poor-risk peripheral T-NHL

Upload

This paper is made freely available by the publisher.

2019 Sylvain Chantepie

ORCID

, Ibrahim Yakoub-Agha, Gandhi Damaj

ORCID

Be ever cautious until the truth is proven

Download from api.wiley.com

Missing publications? Search for publications with a matching author name.